A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Active, not recruiting · NCT07391761 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Not stated | 2026-07-01 | NCT07391761 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kaohsiung Chang Gung Memorial Hospital | Kachsiung | Taiwan | 1 |
| Linkou Chang Gung Memorial Hospital | Taoyuan | Taiwan | 28 |
| Taichung Veterans General Hospital | Taichung | Taiwan | 111 |
| Taipei Veterans General Hospital | Taipei | Taiwan | 189 |